3 Year Absolute Returns
97.43% ↑
NAV (₹) on 19 Dec 2025
322.85
1 Day NAV Change
1.06%
Risk Level
Very High Risk
Rating
-
UTI Healthcare Fund - Direct Plan is a Equity mutual fund categorized under Sector, offered by UTI Asset Management Co. Ltd.. Launched on 01 Jan 2013, investors can start with a minimum SIP of ₹100 or ... Read more
AUM
₹ 1,126.13 Cr
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 71.71% |
| Hospitals & Medical Services | 22.50% |
| Current Assets | 2.66% |
| Chemicals - Speciality | 1.18% |
| Medical Research Services | 1.10% |
| Medical Equipment & Accessories | 0.85% |
| Short Term Deposits | 0.01% |
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| SUN PHARMACEUTICALS INDUSTRIES | 10.44% | ₹ 110.89 | Pharmaceuticals |
| CIPLA LTD. | 5.52% | ₹ 58.63 | Pharmaceuticals |
| DR REDDYS LABORATORIES LTD. | 4.66% | ₹ 49.55 | Pharmaceuticals |
| PROCTOR & GAMBLE HEALTH LTD | 4.34% | ₹ 46.15 | Pharmaceuticals |
| AJANTA PHARMA LTD. | 4.09% | ₹ 43.39 | Pharmaceuticals |
| GLENMARK PHARMACEUTICALS LTD. | 3.78% | ₹ 40.11 | Pharmaceuticals |
| APOLLO HOSPITALS ENTERPRISE LT | 3.65% | ₹ 38.72 | Hospitals & Medical Services |
| DIVIS LABORATORIES LTD. | 3.49% | ₹ 37.03 | Pharmaceuticals |
| FORTIS HEALTHCARE LTD. | 3.09% | ₹ 32.84 | Hospitals & Medical Services |
| ERIS LIFESCIENCES LTD | 3.04% | ₹ 32.34 | Pharmaceuticals |
| JUPITER LIFE LINE HOSPITALS LTD | 2.95% | ₹ 31.35 | Hospitals & Medical Services |
| KRISHNA INSTITUTE OF MEDI SCIE | 2.77% | ₹ 29.45 | Hospitals & Medical Services |
| AUROBINDO PHARMA LTD. | 2.70% | ₹ 28.70 | Pharmaceuticals |
| GLAND PHARMA LTD. | 2.69% | ₹ 28.59 | Pharmaceuticals |
| MAX HEALTHCARE INSTITUTE LTD | 2.67% | ₹ 28.35 | Hospitals & Medical Services |
| NET CURRENT ASSETS | 2.66% | ₹ 28.25 | Others |
| COHANCE LIFESCIENCES LIMITED | 2.65% | ₹ 28.13 | Pharmaceuticals |
| LUPIN LTD. | 2.58% | ₹ 27.41 | Pharmaceuticals |
| CAPLIN POINT LABORATORIES LTD | 2.53% | ₹ 26.83 | Pharmaceuticals |
| IPCA LABORATORIES LTD. | 2.06% | ₹ 21.89 | Pharmaceuticals |
| ASTER DM HEALTHCARE LTD | 2.03% | ₹ 21.57 | Hospitals & Medical Services |
| ALKEM LABORATORIES LTD | 1.92% | ₹ 20.39 | Pharmaceuticals |
| ZYDUS LIFESCIENCES LTD | 1.91% | ₹ 20.26 | Pharmaceuticals |
| GLOBAL HEALTH LTD. | 1.73% | ₹ 18.39 | Hospitals & Medical Services |
| PFIZER LIMITED | 1.64% | ₹ 17.41 | Pharmaceuticals |
| MARKSANS PHARMA LTD. | 1.64% | ₹ 17.41 | Pharmaceuticals |
| METROPOLIS HEALTHCARE LTD | 1.58% | ₹ 16.80 | Hospitals & Medical Services |
| SEQUENT SCIENTIFIC LTD | 1.57% | ₹ 16.71 | Pharmaceuticals |
| WINDLAS BIOTEC LTD | 1.30% | ₹ 13.80 | Pharmaceuticals |
| TORRENT PHARMACEUTICALS LTD. | 1.28% | ₹ 13.60 | Pharmaceuticals |
| VIJAYA DIAGNOSTIC CENTRE LTD | 1.26% | ₹ 13.39 | Hospitals & Medical Services |
| SANOFI CONSUMER HEALTHCARE INDIA LTD | 1.18% | ₹ 12.54 | Chemicals - Speciality |
| SYNGENE INTERNATIONAL LTD. | 1.10% | ₹ 11.64 | Medical Research Services |
| ALEMBIC PHARMACEUTICALS | 1.06% | ₹ 11.31 | Pharmaceuticals |
| AMI ORGANICS LTD | 0.99% | ₹ 10.50 | Pharmaceuticals |
| JUBILANT PHARMOVA LIMITED | 0.99% | ₹ 10.53 | Pharmaceuticals |
| EMCURE PHARMACEUTICALS LTD | 0.88% | ₹ 9.31 | Pharmaceuticals |
| LAXMI DENTAL LIMITED | 0.85% | ₹ 9.04 | Medical Equipment & Accessories |
| RAINBOW CHILDRENS MEDICARE LTD | 0.77% | ₹ 8.14 | Hospitals & Medical Services |
| SAI LIFE SCIENCES LTD | 0.72% | ₹ 7.60 | Pharmaceuticals |
| ORCHID PHARMA LTD. | 0.71% | ₹ 7.54 | Pharmaceuticals |
| CONCORD BIOTECH LTD | 0.53% | ₹ 5.63 | Pharmaceuticals |
| CLEARING CORPORATION OF INDIA LTD. STD - MARGIN | 0.01% | ₹ 0.11 | Others |
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 8.70% | -0.47% | 20.51% | 25.45% |
| Category returns | 12.40% | 1.86% | 16.00% | 25.85% |
An open-ended fund which exclusively invests in the equities of the Pharma & Healthcare sector companies. This fund is one of the growth sector funds aiming to invest in companies engaged in ... Read more
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
UTI Unit Linked Insurance Plan (ULIP) - Direct Plan
Hybrid
Direct
|
₹45.77 | 4.59% | 32.26% | 53.23% | ₹5,300 | 1.03% |
High
|
|
UTI Large Cap Fund
Largecap
Regular
|
₹55.71 | 4.07% | 32.16% | 59.67% | ₹13,399 | 1.74% |
Very High
|
|
UTI Childrens Hybrid Fund - Direct Plan
Hybrid
Direct
|
₹41.70 | 4.37% | 31.12% | 58.99% | ₹4,559 | 1.58% |
High
|
|
UTI Childrens Hybrid Fund - Direct Plan
Hybrid
Direct
|
₹41.70 | 4.37% | 31.12% | 58.99% | ₹4,559 | 1.58% |
High
|
|
UTI Conservative Hybrid Fund
Hybrid
Regular
|
₹70.37 | 5.48% | 30.92% | 54.97% | ₹1,701 | 1.80% |
Moderately High
|
|
UTI Conservative Hybrid Fund
Hybrid
Regular
|
₹70.40 | 5.48% | 30.92% | 54.97% | ₹1,701 | 1.80% |
Moderately High
|
|
UTI Childrens Hybrid Fund
Hybrid
Regular
|
₹40.75 | 4.18% | 30.33% | 57.36% | ₹4,559 | 1.73% |
High
|
|
UTI Childrens Hybrid Fund
Hybrid
Regular
|
₹40.75 | 4.18% | 30.33% | 57.36% | ₹4,559 | 1.73% |
High
|
|
UTI Unit Linked Insurance Plan (ULIP) - Fifteen Year Plan
Hybrid
Regular
|
₹42.20 | 3.92% | 29.56% | 47.84% | ₹5,300 | 1.66% |
High
|
|
UTI Unit Linked Insurance Plan (ULIP) - Ten Year Plan
Hybrid
Regular
|
₹42.20 | 3.92% | 29.56% | 47.84% | ₹5,300 | 1.64% |
High
|
What is the current NAV of UTI Healthcare Fund - Direct Plan Growth?
The current Net Asset Value (NAV) of UTI Healthcare Fund - Direct Plan Growth is ₹322.85 as of 19 Dec 2025. NAV represents the per-unit market value of the fund and is updated daily based on the closing prices of the underlying securities.
What is the fund size (AUM) of UTI Healthcare Fund - Direct Plan Growth?
The Assets Under Management (AUM) of UTI Healthcare Fund - Direct Plan Growth is ₹1,126.13 Crores. AUM indicates the total market value of assets managed by the fund and reflects investor confidence and fund popularity.
What are the historical returns of UTI Healthcare Fund - Direct Plan Growth?
UTI Healthcare Fund - Direct Plan Growth has delivered returns of -0.47% (1 Year), 25.45% (3 Year), 16.32% (5 Year). Past performance does not guarantee future results, and investors should consider their risk appetite before investing.
What is the risk level of UTI Healthcare Fund - Direct Plan Growth?
UTI Healthcare Fund - Direct Plan Growth has a risk rating of 'Very High' as per the SEBI Riskometer. This indicates the fund is suitable for very aggressive investors comfortable with significant market volatility. Investors should align their investment choices with their personal risk tolerance and financial goals.
What is the minimum investment amount for UTI Healthcare Fund - Direct Plan Growth?
The minimum lumpsum investment required for UTI Healthcare Fund - Direct Plan Growth is ₹5,000. The fund also offers SIP (Systematic Investment Plan) option starting from as low as ₹500, making it accessible for regular investments. This allows investors to start their mutual fund journey with a manageable amount.
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article